The CDC page outlines the importance of medication-assisted treatment (MAT) for opioid use disorder (OUD) during pregnancy, emphasizing methadone and buprenorphine as effective options to improve maternal and neonatal outcomes. It also highlights the need for comprehensive care, including mental health support, to reduce relapse risks and manage withdrawal symptoms in newborns.
